Pages that link to "Q40924091"

The following pages link to Role of Complement in Host Defense against Experimental Disseminated Candidiasis (Q40924091):

Displaying 35 items.

• Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice (Q30804794) (← links)
• Influence of mannan and glucan on complement activation and C3 binding by Candida albicans (Q33675896) (← links)
• Mannan-specific immunoglobulin G antibodies in normal human serum accelerate binding of C3 to Candida albicans via the alternative complement pathway. (Q33765773) (← links)
• Activation of the alternative complement pathway by Histoplasma capsulatum (Q33909027) (← links)
• Alterations in Lung Macrophage Antimicrobial Activity Associated with Viral Pneumonia (Q34096887) (← links)
• Alternate complement pathway activation by group A streptococci: role of M-protein (Q34101448) (← links)
• Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans (Q34125581) (← links)
• Canadian Clinical Practice Guidelines for Invasive Candidiasis in Adults (Q34237335) (← links)
• The Pathophysiology and Treatment of Candida Sepsis (Q34848032) (← links)
• Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans (Q35513657) (← links)
• Acute lethal toxicity following passive immunization for treatment of murine cryptococcosis (Q35546751) (← links)
• Mannan-specific immunoglobulin G antibodies in normal human serum mediate classical pathway initiation of C3 binding to Candida albicans (Q35555410) (← links)
• A monoclonal antibody to Candida albicans enhances mouse neutrophil candidacidal activity (Q35561235) (← links)
• The role of complement in invasive fungal infections (Q35743823) (← links)
• Genetic analysis of innate immunity in resistance to Candida albicans (Q35889577) (← links)
• Immune responses to Candida albicans in genetically distinct mice. (Q36339441) (← links)
• Activation and binding of C3 by Candida albicans. (Q37021874) (← links)
• Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans (Q37161587) (← links)
• Complement and fungal pathogens: an update (Q37244273) (← links)
• Complement C3 plays an essential role in the control of opportunistic fungal infections (Q37333509) (← links)
• Massive induction of innate immune response to Candida albicans in the kidney in a murine intravenous challenge model. (Q37442471) (← links)
• Immunological aspects of fungal pathogenesis (Q37957849) (← links)
• Host-parasite interaction in fungal infections (Q38223670) (← links)
• The yeast Candida albicans binds complement regulators factor H and FHL-1. (Q39656217) (← links)
• Activation of the complement system by pathogenic fungi (Q39820650) (← links)
• Immunity to Fungal Infections (Q40152478) (← links)
• Activation of the alternative complement pathway by Sporothrix schenckii (Q40165973) (← links)
• Infections in burn patients: A paradigm for cutaneous infection in the patient at risk (Q40176670) (← links)
• Infectious complications in the child with cancer. I. Pathophysiology of the compromised host and the initial evaluation and management of the febrile cancer patient (Q40300808) (← links)
• Genetic control of susceptibility to Candida albicans in susceptible A/J and resistant C57BL/6J mice (Q44115977) (← links)
• Murine candidiasis: Sex differences in the severity of tissue lesions are not associated with levels of serum C3 and C5 (Q44315428) (← links)
• Interaction and intracellular killing of Candida albicans blastospores by human polymorphonuclear leucocytes, monocytes and monocyte-derived macrophages in aerobic and anaerobic conditions (Q67485923) (← links)
• Chronic mucocutaneous candidiasis (Q69216250) (← links)
• Activation of Complement by Pityrosporum orbiculare (Q70239136) (← links)
• Complement activation by pathogenic fungi (Q77164019) (← links)